Performance of RGNX Regenxbio | -19.8% in 12m

Compare RGNX with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?

Compare Regenxbio with its related Sector/Index XBI

Compare Regenxbio with its related Sector/Index XBI

Performance Duell RGNX vs XBI

TimeFrame RGNX XBI
1 Day -4.18% 0.64%
1 Week -7.54% 1.72%
1 Month 22.69% 6.19%
3 Months -10.72% 28.65%
6 Months -3.17% 20.17%
12 Months -19.77% 13.54%
YTD -5.07% 5.01%
Rel. Perf. 1m 1.74
Rel. Perf. 3m -1.84
Rel. Perf. 6m -1.88
Rel. Perf. 12m -3.13

Is Regenxbio a good stock to buy?

No, based on ValueRay Fundamental Analyses, Regenxbio (NASDAQ:RGNX) is currently (February 2024) a stock to sell. It has a ValueRay Fundamental Rating of -7.52 and therefor a negative outlook.
Based on ValueRays Technical Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of RGNX as of February 2024 is 13.70. This means that RGNX is currently overvalued and has a potential downside of -21.31%.

Is RGNX a buy, sell or hold?

Regenxbio has received a consensus analysts rating of 4.20. Therefor, it is recommend to buy RGNX.
  • Strong Buy: 5
  • Buy: 2
  • Hold: 3
  • Sell: 0
  • Strong Sell: 0
Values above 0%: RGNX is performing better - Values below 0%: RGNX is underperforming

Compare RGNX with Broad Market Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY -9.21% 17.95% -18.67% -48.45%
US NASDAQ 100 QQQ -8.98% 19.55% -21.97% -67.94%
US Dow Jones Industrial 30 DIA -8.86% 19.30% -17.74% -40.06%
German DAX 40 DBXD -9.32% 18.00% -13.81% -31.72%
UK FTSE 100 ISFU -8.31% 19.54% -9.58% -26.48%
Shanghai Shenzhen CSI 300 CSI 300 -9.80% 16.22% 1.53% -2.57%
Hongkong Hang Seng HSI -9.25% 17.56% 0.50% -4.26%
Japan Nikkei 225 EXX7 -9.73% 15.23% -22.72% -47.91%
India NIFTY 50 INDA -8.71% 16.28% -20.39% -51.49%
Brasil Bovespa EWZ -7.57% 22.14% -10.61% -42.86%

RGNX Regenxbio vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC -8.52% 17.41% -23.48% -68.81%
Consumer Discretionary XLY -8.81% 18.32% -12.71% -44.88%
Consumer Staples XLP -9.59% 19.52% -7.66% -24.65%
Energy XLE -8.00% 16.09% -3.26% -24.93%
Financial XLF -9.23% 17.11% -22.99% -35.03%
Health Care XLV -9.08% 17.05% -14.79% -35.24%
Industrial XLI -9.40% 16.52% -16.65% -41.05%
Materials XLB -9.49% 17.75% -11.77% -29.73%
Real Estate XLRE -8.50% 22.56% -11.18% -23.02%
Technology XLK -8.88% 20.99% -23.78% -69.22%
Utilities XLU -8.73% 20.75% -2.43% -15.93%
Aerospace & Defense XAR -6.88% 19.92% -14.52% -32.98%
Biotech XBI -9.26% 16.50% -23.34% -33.31%
Homebuilder XHB -10.53% 15.10% -29.22% -71.81%
Retail XRT -8.98% 15.09% -22.37% -31.69%

RGNX Regenxbio vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO -5.51% 19.45% -3.95% -28.12%
Natural Gas UNG -9.01% 47.09% 39.30% 33.11%
Gold GLD -8.76% 22.33% -9.20% -31.00%
Silver SLV -5.67% 20.45% 2.66% -26.70%
Copper CPER -8.76% 20.88% -5.68% -17.66%

Returns of RGNX vs. Yields & Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT -8.74% 22.40% -3.32% -14.78%
iShares High Yield Corp. Bond HYG -8.11% 21.92% -9.82% -29.79%

Why you should compare the Total Return of Regenxbio?

Total Returns are not just stock price changes but also Dividends and other income sources, offering a better overview of investment outcomes.
ValueRay compares the Total Return of Regenxbio (last price 17.41) with its related Sector/Index XBI (SPDR S&P Biotech). Its a Technical Analysis that provides investors with a comprehensive perspective on the company's performance. This comparison allows investors to assess how RGNX Regenxbio returns stack up against the performance of its broader sector, the XBI. This analysis assists investors in making well-informed decisions about their investments. It provides insights into whether Regenxbio is outperforming or underperforming its sector in terms of Total Returns.

Does Regenxbio outperforms the market?

No, over the last 12 months Regenxbio (RGNX) made -19.77%, while its related Sector, the SPDR S&P Biotech (XBI) made 13.54%.
Over the last 3 months RGNX made -10.72%, while XBI made 28.65%.